Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash $ 10,950,927 $ 10,574,292
Prepaid expenses and other current assets 554,321 54,537
Australia research and development incentives receivable 302,789 43,666
Total current assets 11,808,037 10,672,495
Deferred offering costs 211,203 651,582
Other assets 2,800 3,122
Total assets 12,022,040 11,327,199
Current liabilities:    
Accounts payable 1,165,505 960,401
Accrued expenses 2,103,401 1,185,595
Total current liabilities 3,268,906 2,145,996
Long term liabilities:    
Warrant liability 245,341  
Total liabilities 3,514,247 2,145,996
Commitments and contingencies (Note 5)
Stockholders' equity (deficit)    
Preferred stock, $0.0001 par value, 30,000,000 and 70,000,000 shares authorized at December 31, 2022 and December 31, 2021 respectively,0 shares issued and outstanding
Common stock, $0.0001 par value, 70,000,000 and 30,000,000 shares authorized at December 31, 2022 and December 31, 2021 respectively,10,955,904 and 7,584,980 shares issued and outstanding at December 31,2022 and December 31, 2021, respectively 1,096 758
Additional paid-in capital 52,729,942 37,618,438
Accumulated deficit (44,207,272) (28,437,993)
Accumulated other comprehensive loss (15,973)  
Total stockholders' equity 8,507,793 9,181,203
Total liabilities and stockholders' equity $ 12,022,040 $ 11,327,199